12.16.14
Norwich Pharma Services has refined its business strategy to focus on customers with commercial phase programs. In addition to its manufacturing services, Norwich will continue to offer clinical research services including: pharmacokinetics studies in healthy volunteers; drug metabolism studies; dose proportionality studies; and multiple dose studies. Norwich also offers pharmacovigilance services for pre-marketing, product safety, post-marketing surveillance and data analysis.
“Norwich’s service offering centers around what we do best – commercial manufacturing of solid dosage products,” said John Bender, Norwich’s vice president of commercial operations. “The Norwich team will support programs at registration or post approval stages. Our 375,000 square foot facility has available commercial capacity and can easily accommodate large-scale projects that require a wide variety of technology platforms.”
“Norwich’s service offering centers around what we do best – commercial manufacturing of solid dosage products,” said John Bender, Norwich’s vice president of commercial operations. “The Norwich team will support programs at registration or post approval stages. Our 375,000 square foot facility has available commercial capacity and can easily accommodate large-scale projects that require a wide variety of technology platforms.”